113 related articles for article (PubMed ID: 32896889)
1. Hypoglycaemia assessment tool (HAT) study: subanalysis of the Lebanese cohort.
Amm M; Rawas M; Francis Z; Chehabeddine M; Chalfoun A; El Akel M; Merheb M
East Mediterr Health J; 2020 Aug; 26(8):939-947. PubMed ID: 32896889
[TBL] [Abstract][Full Text] [Related]
2. Self-reported Hypoglycaemic Events in 2 430 Patients with Insulin-treated Diabetes in the German Sub-population of the HAT Study.
Kern W; Holstein A; Moenninghoff C; Kienhöfer J; Riedl M; Kulzer B
Exp Clin Endocrinol Diabetes; 2017 Oct; 125(9):592-597. PubMed ID: 28750429
[TBL] [Abstract][Full Text] [Related]
3. Rates and predictors of hypoglycaemia in 27 585 people from 24 countries with insulin-treated type 1 and type 2 diabetes: the global HAT study.
Khunti K; Alsifri S; Aronson R; Cigrovski Berković M; Enters-Weijnen C; Forsén T; Galstyan G; Geelhoed-Duijvestijn P; Goldfracht M; Gydesen H; Kapur R; Lalic N; Ludvik B; Moberg E; Pedersen-Bjergaard U; Ramachandran A;
Diabetes Obes Metab; 2016 Sep; 18(9):907-15. PubMed ID: 27161418
[TBL] [Abstract][Full Text] [Related]
4. Self-reported hypoglycaemia in insulin-treated patients with diabetes mellitus: results from the Singapore cohort of the International Operations Hypoglycaemia Assessment Tool study.
Tan NC; Goh SY; Khoo EY; Dalan R; Koong A; Khoo CM; Tan TS; Jain AB; Gadekar AV; Bee YM;
Singapore Med J; 2020 Mar; 61(3):129-136. PubMed ID: 32488272
[TBL] [Abstract][Full Text] [Related]
5. Frequency and predictors of confirmed hypoglycaemia in type 1 and insulin-treated type 2 diabetes mellitus patients in a real-life setting: results from the DIALOG study.
Cariou B; Fontaine P; Eschwege E; Lièvre M; Gouet D; Huet D; Madani S; Lavigne S; Charbonnel B
Diabetes Metab; 2015 Apr; 41(2):116-25. PubMed ID: 25465273
[TBL] [Abstract][Full Text] [Related]
6. Hypoglycaemia Among Insulin-Treated Patients with Diabetes: Evaluation of the United Arab Emirates cohort of the International Operations-Hypoglycaemia Assessment Tool study.
Abusnana S; Beshyah SA; Al-Mutawa N; Tahhan R; Jallo M; Arora R; Aly H; Singhal S
Sultan Qaboos Univ Med J; 2018 Nov; 18(4):e447-e454. PubMed ID: 30988962
[TBL] [Abstract][Full Text] [Related]
7. Indonesia Cohort of IO HAT Study to Evaluate Diabetes Management, Control, and Complications in Retrospective and Prospective Periods Among Insulin-Treated Patients with Type 1 and Type 2 Diabetes.
Rudijanto A; Saraswati MR; Yunir E; Kumala P; Puteri HH; Mandang VV
Acta Med Indones; 2018 Jan; 50(1):26-37. PubMed ID: 29686173
[TBL] [Abstract][Full Text] [Related]
8. Hypoglycemia awareness among insulin-treated patients with diabetes in Malaysia: A cohort subanalysis of the HAT study.
Hussein Z; Kamaruddin NA; Chan SP; Jain A; Uppal S; Bebakar WMW;
Diabetes Res Clin Pract; 2017 Nov; 133():40-49. PubMed ID: 28888148
[TBL] [Abstract][Full Text] [Related]
9. [Hypoglycaemia in patients with type 1 and type 2 diabetes mellitus on insulin therapy. Results of the global HAT study in Argentina].
Costa Gil JE; Linari MA; Pugnaloni N; Zambon FG; Pérez Manghi F; Rezzónico M;
Medicina (B Aires); 2017; 77(6):449-457. PubMed ID: 29223934
[TBL] [Abstract][Full Text] [Related]
10. Patient-reported frequency, awareness and patient-physician communication of hypoglycaemia in Belgium.
Peene B; D'Hooge D; Vandebrouck T; Mathieu C
Acta Clin Belg; 2014 Dec; 69(6):439-45. PubMed ID: 25212241
[TBL] [Abstract][Full Text] [Related]
11. An international survey on hypoglycemia among insulin-treated type I and type II diabetes patients: Turkey cohort of the non-interventional IO HAT study.
Emral R; Tetiker T; Sahin I; Sari R; Kaya A; Yetkin İ; Cil SU; Tütüncü NB;
BMC Endocr Disord; 2018 Feb; 18(1):9. PubMed ID: 29433560
[TBL] [Abstract][Full Text] [Related]
12. Impact of hypoglycaemia on patient-reported outcomes from a global, 24-country study of 27,585 people with type 1 and insulin-treated type 2 diabetes.
Khunti K; Alsifri S; Aronson R; Cigrovski Berković M; Enters-Weijnen C; Forsén T; Galstyan G; Geelhoed-Duijvestijn P; Goldfracht M; Gydesen H; Kapur R; Lalic N; Ludvik B; Moberg E; Pedersen-Bjergaard U; Ramachandran A;
Diabetes Res Clin Pract; 2017 Aug; 130():121-129. PubMed ID: 28602812
[TBL] [Abstract][Full Text] [Related]
13. The Canadian Hypoglycemia Assessment Tool Program: Insights Into Rates and Implications of Hypoglycemia From an Observational Study.
Aronson R; Goldenberg R; Boras D; Skovgaard R; Bajaj H
Can J Diabetes; 2018 Feb; 42(1):11-17. PubMed ID: 28528246
[TBL] [Abstract][Full Text] [Related]
14. Survey on hypoglycemia among insulin-treated patients with diabetes: The Colombian International Operations Hypoglycemia Assessment Tool population.
Gómez AM; Chica LG; Burbano ÁF; Vásquez EM; Escobar JA; Arias PM; Molina DI
Biomedica; 2019 Sep; 39(3):576-586. PubMed ID: 31584770
[TBL] [Abstract][Full Text] [Related]
15. A cost of illness study of hypoglycaemic events in insulin-treated diabetes in the Netherlands.
de Groot S; Enters-Weijnen CF; Geelhoed-Duijvestijn PH; Kanters TA
BMJ Open; 2018 Mar; 8(3):e019864. PubMed ID: 29581204
[TBL] [Abstract][Full Text] [Related]
16. Severe (level 3) hypoglycaemia occurrence in a real-world cohort of adults with type 1 or 2 diabetes mellitus (iNPHORM, United States).
Ratzki-Leewing A; Black JE; Kahkoska AR; Ryan BL; Zou G; Klar N; Timcevska K; Harris SB
Diabetes Obes Metab; 2023 Dec; 25(12):3736-3747. PubMed ID: 37700692
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the HAT study, the largest global hypoglycaemia study to date, with similar large real-world studies.
Pedersen-Bjergaard U; Alsifri S; Aronson R; Berković MC; Galstyan G; Gydesen H; Lekdorf JB; Ludvik B; Moberg E; Ramachandran A; Khunti K
Diabetes Obes Metab; 2019 Apr; 21(4):844-853. PubMed ID: 30456887
[TBL] [Abstract][Full Text] [Related]
18. (Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus.
Semlitsch T; Engler J; Siebenhofer A; Jeitler K; Berghold A; Horvath K
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD005613. PubMed ID: 33166419
[TBL] [Abstract][Full Text] [Related]
19. Elderly patients with diabetes experience a lower rate of nocturnal hypoglycaemia with insulin degludec than with insulin glargine: a meta-analysis of phase IIIa trials.
Sorli C; Warren M; Oyer D; Mersebach H; Johansen T; Gough SC
Drugs Aging; 2013 Dec; 30(12):1009-18. PubMed ID: 24170235
[TBL] [Abstract][Full Text] [Related]
20. Self-reported non-severe hypoglycaemic events in Europe.
Östenson CG; Geelhoed-Duijvestijn P; Lahtela J; Weitgasser R; Markert Jensen M; Pedersen-Bjergaard U
Diabet Med; 2014 Jan; 31(1):92-101. PubMed ID: 23796113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
